Page last updated: 2024-11-07

prednisone and Malignant Mesothelioma

prednisone has been researched along with Malignant Mesothelioma in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lococo, F1
Di Stefano, T1
Rapicetta, C1
Piro, R1
Gelli, MC1
Muratore, F1
Ricchetti, T1
Taddei, S1
Zizzo, M1
Cesario, A1
Facciolongo, N1
Paci, M1

Other Studies

1 other study available for prednisone and Malignant Mesothelioma

ArticleYear
Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma.
    Lung, 2019, Volume: 197, Issue:3

    Topics: Aged; Bronchoscopy; Diagnosis, Differential; Endosonography; Glucocorticoids; Humans; Immunoglobulin

2019